Venture Partners at CU 鶹 is partnering with BridgeBio to advance novel drug discovery with an underlying genetic basis. Apply by Monday, March 16, 2020.
Vu, an assistant professor in the Department of Computer Science, is improving human cognitive functions using an ear-worn device. To bring the technology to customers worldwide later in 2020, he founded Earable Inc., which now has more than 15 employees.
This year's event — hosted again by Venture Partners at CU 鶹 on Feb. 27 — will feature 18 startups from CU 鶹, CU Anschutz, CU Denver, University of Colorado Colorado Springs, Colorado State University, Colorado School of Mines and NIST.
Randolph, a professor in the Department of Chemical and Biological Engineering, founded VitriVax, a CU 鶹 spinout, to commercialize new applications of atomic layer deposition techniques for producing thermally stable vaccines.
Six 鶹-based startups with ties to CU 鶹 were recognized for their innovation with $1.5 million in grants from the Colorado Office of Economic Development and International Trade.
Inscripta, a digital genome engineering company spun out of CU 鶹 research, has just raised another $125 million in a Series D financing on the heels of launching its revolutionary product, The Onyx™.
Led by its current investors Maverick Ventures and Global Frontier Investments, the funding will be used to advance the development of ColdQuanta’s cold atom Quantum Core technology, the foundation for the company’s development of quantum computers.
The Insider is Venture Partners at CU 鶹's monthly newsletter featuring the latest headlines, news, events, opportunities and emerging innovations coming out of the university. We have several editions for our audiences: